Protein C Activity Test

Your blood has a built-in braking system that prevents clots from growing out of control. Protein C is one of the most powerful components of that system, and when it is not working well enough, clots can form in your deep veins or travel to your lungs without any warning. The problem is that standard blood tests never measure it, so most people with low protein C activity have no idea they are carrying this risk.

This test measures how well your protein C actually functions, not just how much of it is floating around. That distinction matters because some people produce normal amounts of protein C that does not work properly. A functional activity test catches both problems: too little protein C and protein C that is structurally abnormal.

How Protein C Keeps You Safe

When a blood vessel is damaged, your body triggers a clotting cascade to seal the wound. Protein C acts as a counterbalance to that cascade. Once clotting begins, a molecule on the surface of blood vessel walls called thrombomodulin captures thrombin (the enzyme that builds clots) and flips its role. Instead of making more clot, thrombin activates protein C. The activated form then shuts down two key clotting amplifiers (factors Va and VIIIa), slowing clot growth before it blocks the vessel.

Protein C also has anti-inflammatory properties. It helps protect the cells lining your blood vessels from damage during infection and stress. This dual role explains why protein C deficiency matters far beyond clotting: it shows up as a predictor of outcomes in conditions ranging from stroke to severe infection.

Blood Clot Risk

Low protein C activity is one of the stronger inherited risk factors for venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). A meta-analysis of 11 studies covering 2,554 cases and 9,355 controls found that protein C deficiency was associated with roughly 7.5 times the odds of a first VTE event. In families where a member has already had a clot, a prospective study following 382 relatives found that those with protein C deficiency had about 7 times the risk of VTE compared to family members without it, after adjusting for age.

The ARIC study, a large population-based study that followed participants for an average of 8.1 years, confirmed this gradient in the general population. People with protein C levels below the 5th percentile had significantly higher VTE incidence than those with higher levels. The Leiden Thrombophilia Study found a clear dose-response relationship: as protein C activity dropped, clot risk rose.

That said, many people with heterozygous protein C deficiency (meaning they carry one affected copy of the gene) never develop a clot. The risk depends heavily on whether other factors are also present, such as the Factor V Leiden mutation, oral contraceptive use, prolonged immobility, or surgery. Protein C deficiency sets the stage, but it often takes a second hit to trigger an event.

Stroke Risk

The ARIC study also tracked ischemic stroke in 13,879 participants over a median of 16.9 years. People in the lowest fifth of protein C levels had about 52% higher risk of ischemic stroke compared to those in the highest fifth, even after adjusting for standard risk factors like blood pressure and cholesterol. The association was strongest for strokes caused by large vessel disease and cardiac sources, rather than small vessel disease in the brain.

This finding matters for prevention-minded adults because it means low protein C can contribute to stroke risk through mechanisms that standard cardiovascular panels do not capture. If your cholesterol and blood pressure look fine but your protein C is low, you may still carry excess vascular risk.

Severe Illness and Sepsis

When the body fights a severe infection, protein C levels drop dramatically. Over 85% of patients with sepsis develop acquired protein C deficiency, and the degree of that drop strongly predicts survival. A meta-analysis of 12 studies found that sepsis survivors had significantly higher protein C levels than non-survivors. In a study of 1,574 patients with severe sepsis, those whose protein C stayed severely low (at or below 40% activity) by day one had roughly 2.75 times the odds of dying within 28 days compared to those whose levels recovered.

In surgical ICU patients, the minimum protein C concentration reached during a hospital stay was an independent predictor of ICU death, regardless of whether sepsis was present. Protein C deficiency in critical illness reflects widespread activation of clotting in tiny blood vessels throughout the body, cutting off oxygen to organs.

Inherited vs. Acquired Deficiency

There are two fundamentally different reasons your protein C activity might be low. Inherited deficiency comes from mutations in the PROC gene, with over 160 distinct mutations identified. About 0.2% to 0.5% of the population carries a heterozygous mutation, meaning one of their two gene copies is affected. In rare cases where both copies are affected (homozygous deficiency), newborns can develop a life-threatening condition called purpura fulminans, involving widespread clotting, skin death, and organ failure.

Acquired deficiency is far more common. Liver disease reduces protein C production because the liver is where protein C is made. Vitamin K deficiency impairs the chemical modification that protein C needs to function. Warfarin therapy deliberately targets this same pathway, which is why warfarin lowers protein C before it lowers the clotting factors it is meant to suppress. Severe infections, surgery, and active clotting events all consume protein C faster than the body can replace it.

Reference Ranges

Protein C levels vary significantly by age, sex, and the specific lab method used. Before interpreting your result, know that younger adults and premenopausal women tend to have lower levels than older adults and men, and that oral contraceptives raise levels by a small amount. The following tiers are drawn from published clinical guidelines and large population studies.

These tiers are drawn from published research, including ISTH, ACOG, and large reference studies. Your lab may use different assays and cutpoints. Compare your results within the same lab over time for the most meaningful trend. A single reading below 65% should always be confirmed with a repeat test before concluding you have inherited deficiency.

Age and Sex Differences

In a study of 9,648 healthy blood donors, protein C activity in men increased from a mean of 0.86 IU/mL at ages 15 to 19 up to 1.04 IU/mL by ages 45 to 49, then began to decrease after 50. Women showed a more gradual rise, with levels increasing after menopause. Premenopausal women had lower levels than age-matched men, and oral contraceptive use raised levels by 0.05 to 0.08 IU/mL.

These patterns mean that a protein C activity of 68% in a 20-year-old man might be normal for his age, while the same reading in a 50-year-old woman could represent a meaningful drop. Age- and sex-specific reference ranges are strongly recommended for accurate interpretation, though many labs still report a single adult range.

Tracking Your Trend

A single protein C activity reading can be misleading. The within-person variability (the natural fluctuation in your own levels from day to day and week to week) runs between 6.5% and 8.9%, based on modern biological variation studies. That means your true baseline might be a few percentage points higher or lower than any individual draw shows.

This variability is exactly why the Leiden Thrombophilia Study found that basing a deficiency diagnosis on a single measurement gave a relative risk for thrombosis of 3.1, but confirming with a second measurement raised that to 3.8, and DNA confirmation pushed it to 6.5. A single number underestimates the true predictive power of the test.

Get a baseline when you are healthy, not on anticoagulants, and at least six weeks removed from any clotting event, surgery, or acute illness. If the result falls in the deficient or borderline range, retest in 4 to 8 weeks under the same conditions. If you are making lifestyle changes that could affect clotting biology (quitting smoking, losing weight), retest in 3 to 6 months to see whether your trend is moving. After that, annual monitoring gives you a reliable trajectory.

When Results Can Be Misleading

Protein C levels drop during any significant illness, so a low reading during a hospital stay, after surgery, or during an active blood clot does not mean you have inherited deficiency. Levels can fall to 47% to 60% of normal during sepsis and drop significantly after even minor surgeries like appendix removal. Wait at least six weeks after an acute event before testing.

Warfarin is the most common drug confounder. Because protein C is vitamin K-dependent, warfarin suppresses it rapidly, often within 24 hours of starting the drug. If you are tested while on warfarin, your protein C will be low regardless of your true baseline. Stop warfarin at least two weeks before testing (under medical guidance). Direct oral anticoagulants like rivaroxaban and apixaban create the opposite problem: they can falsely elevate protein C readings in certain assay types without actually changing your protein C biology. Wait 2 to 3 days after stopping these medications.

Pregnancy, liver disease, and vitamin K deficiency all lower protein C through biological mechanisms unrelated to inherited deficiency. If your result is low and any of these conditions apply, the deficiency is likely acquired and may resolve when the underlying cause is addressed.